19.17
전일 마감가:
$19.59
열려 있는:
$19.62
하루 거래량:
1.79M
Relative Volume:
0.94
시가총액:
$1.31B
수익:
$1.01B
순이익/손실:
$-204.71M
주가수익비율:
-6.2461
EPS:
-3.0691
순현금흐름:
$-29.67M
1주 성능:
-21.79%
1개월 성능:
-24.23%
6개월 성능:
+57.91%
1년 성능:
+0.05%
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TNDM
Tandem Diabetes Care Inc
|
19.17 | 1.34B | 1.01B | -204.71M | -29.67M | -3.0691 |
|
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-19 | 업그레이드 | Truist | Hold → Buy |
| 2026-03-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | 업그레이드 | Lake Street | Hold → Buy |
| 2026-02-20 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2026-01-27 | 재개 | TD Cowen | Buy |
| 2025-12-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | 재개 | Stifel | Hold |
| 2025-09-08 | 개시 | Oppenheimer | Outperform |
| 2025-08-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-06-16 | 개시 | Truist | Hold |
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
Tandem Diabetes Care Stock Hits Day Low Amid Price Pressure at $20.93 - Markets Mojo
Tandem Diabetes Care (TNDM) reports Q4 earnings: What key metrics have to say - MSN
Stock List: Research Stocks from Around the World - gurufocus.com
Tandem Diabetes and Roche Reach a Patent Settlement - MSN
Board asks shareholders to approve 3.26M-share increase; TNDM files proxy (TNDM) - Stock Titan
Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.6%Time to Sell? - MarketBeat
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - TradingView
[SCHEDULE 13G/A] TANDEM DIABETES CARE INC Amended Passive Investment Disclosure - Stock Titan
Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Mizuho maintains Tandem Diabetes Care (TNDM) neutral recommendation - MSN
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Assenagon Asset Management S.A. Invests $26.99 Million in Tandem Diabetes Care, Inc. $TNDM - MarketBeat
Strength seen in Tandem Diabetes Care (TNDM): Can its 9.1% jump turn into more strength? - msn.com
Tandem Diabetes Care, Inc. (TNDM) reports Q4 loss, tops revenue estimates - MSN
Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch - Yahoo Finance
Here’s why the Brown Capital Management Small Company Fund sold Tandem Diabetes Care (TNDM) - MSN
Reasons to hold Tandem Diabetes stock in your portfolio for now - MSN
US875372AE4 Latest News and Headlines - TradingView
US875372AE4 Bond Analysis — Key Metrics - TradingView
Tandem upgraded at Truist on pharmacy model (TNDM:NASDAQ) - Seeking Alpha
US875372AE4 Bond Price and Chart — FWB:US875372AE4 - TradingView
Tandem Diabetes Care (NASDAQ:TNDM) Stock Price Up 5.3% on Analyst Upgrade - MarketBeat
Nvidia To $323? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga
Truist Financial Upgrades Tandem Diabetes Care (NASDAQ:TNDM) to "Buy" - MarketBeat
Tandem Diabetes Care analysts boost their forecasts after upbeat Q4 results - MSN
Tandem Diabetes (TNDM) Receives Upgrade Amid Revenue Growth Pros - GuruFocus
Tandem Diabetes (TNDM) EVP exercises 7,414 RSUs and sells 187 shares - Stock Titan
Lake Street upgrades Tandem Diabetes Care (TNDM) - MSN
Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength? - Yahoo Finance
Piper Sandler upgrades Tandem Diabetes Care (TNDM) - MSN
Tandem Diabetes (TNDM) Stock Upgraded by Piper Sandler Amid Stra - GuruFocus
Piper Sandler Upgrades Tandem Diabetes Care (TNDM) to Overweight - GuruFocus
Tandem Diabetes Care (TNDM) insider files resale notice; 2 shares sold at $45.62 - Stock Titan
Tandem Diabetes Care Stock Upgrade & Market Outlook 2026News and Statistics - IndexBox
Why Are Tandem Diabetes (TNDM) Shares Soaring Today - Yahoo Finance
Bullish Call On Tandem Diabetes Signals Long-Term Growth Confidence - Benzinga
TNDM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Tandem Diabetes Care (NASDAQ:TNDM) Shares Gap Up on Analyst Upgrade - MarketBeat
Tandem stock rises as Piper Sandler upgrades (TNDM:NASDAQ) - Seeking Alpha
Global Diabetes Care Devices Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight - PR Newswire
Tandem Diabetes Care (NASDAQ:TNDM) Upgraded at Piper Sandler - MarketBeat
Semtech To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
This Lemonade Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Tops Revenue Estimates - MSN
Aug Opening: Should value investors consider Tandem Diabetes Care IncDollar Strength & Risk Managed Investment Entry Signals - baoquankhu1.vn
Assessing Tandem Diabetes Care (TNDM) Valuation After Mixed Long Term Returns And Recent Share Price Strength - Sahm
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tandem Diabetes Care Inc 주식 (TNDM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Novara Mark David | EVP & CHIEF COMMERCIAL OFFICER |
Mar 17 '26 |
Sale |
23.05 |
187 |
4,310 |
37,656 |
자본화:
|
볼륨(24시간):